REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Abbisko Cayman Limited (China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Abbisko Cayman Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Abbisko Cayman Limited is committed to the discovery and innovation of differentiated small molecule tumor therapy. The company was founded in 2018 and headquartered in Shanghai City, China.

Headquarters
Building 3, No. 898, Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Prc
Shanghai; Shanghai;

Contact Details: Purchase the Abbisko Cayman Limited report to view the information.

Website: http://www.abbisko.com

Basic Information
Total Employees:
Purchase the Abbisko Cayman Limited report to view the information.
Outstanding Shares:
Purchase the Abbisko Cayman Limited report to view the information.
Registered Capital:
Purchase the Abbisko Cayman Limited report to view the information.
Financial Auditors:
Purchase the Abbisko Cayman Limited report to view the information.
Incorporation Date:
March 28, 2018
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
6.74%
Purchase this report to view the information.
6.63%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Abbisko Hongkong Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after Abbisko Cayman Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
2508.99%▲
Total operating revenue
2508.99%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-3.8%▼
Total equity
-4.19%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.39%▼
Quick Ratio
-4.81%▼
Cash Ratio
-3.57%▼

Similar companies

Brii Biosciences Limited
 
JW Cayman Therapeutics Company Limited
Hua Medicine (Shanghai) (华领医药 (上海))
 
Ascentage Pharma Group International (Hong Kong) (亚盛医药集团-B (香港))
Pharmaron Beijing Co., Ltd. (康龙化成(北京)新药技术股份有限公司)
 
Bloomage Biotechnology Corporation Limited
Shanghai Haohai Biological Technology Co.,Ltd
 
Shandong Boan Biotechnology Company Limited (Heze) (山东博安生物技术股份有限公司 (菏泽))
Boji Medical Technology Co.,Ltd.
 
Jiangsu Bioperfectus Technologies Co., Ltd.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo